Cargando...
Progress of immune checkpoint LAG-3 in immunotherapy
Immune checkpoint inhibition has been shown to successfully reactivate T cell responses directed against tumor-associated antigens, resulting in significantly prolonged overall survival in patients with various types of solid tumors. Among them, cytotoxic T-lymphocyte protein 4 (CTLA-4) and programm...
Gardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7491111/ https://ncbi.nlm.nih.gov/pubmed/32963613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12070 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|